Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NYC-0462 Ointment in Plaque Psoriasis
NCT00747032Phase 3Withdrawn
- Sponsor
- Fougera Pharmaceuticals Inc.
- Start
- Sep 2010
- Primary completion
- Feb 2011
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of calcipotriol in plaque psoriasis, sponsored by Fougera Pharmaceuticals Inc.. Planned start Sep 2010; status: withdrawn.
02
Drugs
calcipotriol
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00747032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00747032.